跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONUREG 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ONUREG 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ONUREG 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Bristol-Myers Squibb Pharma Eeig
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 22, 2021
Approval ID
1f84f18aa3332651
Company
Bristol-Myers Squibb Pharma Eeig
Type
Standard
Approval Details
Approval Id
1f84f18aa3332651
Drug Cima Aemps Name
ONUREG 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1211556003
Holder Company Name
Bristol-Myers Squibb Pharma Eeig
Marketing Company Name
Bristol Myers Squibb S.A.
Holder Company Detail Path
/organization/bristol-myers-squibb-pharma-eeig
Authorization Date
2021-07-22
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
300 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Bristol-Myers Squibb Pharma Eeig
Company Detail Path
/organization/bristol-myers-squibb-pharma-eeig
Company Information
Pharmaceutical Company Name
Bristol-Myers Squibb Pharma EEIG
Country Name
Ireland
Active Ingredients
AZACITIDINA
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 22, 2021
Approval ID
1f84f18aa3332651
Type
Standard
Back to CIMA-AEMPS Approvals
